ABCC7 p.Ile175Val

[switch to full view]
Comments [show]
Publications
PMID: 19491324 [PubMed] Caputo A et al: "Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators."
No. Sentence Comment
91 To this respect, we considered I148T, I175V, Q179K, and E193K in ICL1 (Seibert et al., 1997) and G970R in ICL3 (Seibert et al., 1996).
X
ABCC7 p.Ile175Val 19491324:91:38
status: NEW
Login to comment

100 This discrepancy was even more striking for I175V, which was associated with an anion transport rate greater than wild-type CFTR.
X
ABCC7 p.Ile175Val 19491324:100:44
status: NEW
Login to comment

120 The activity of I175V was also not significantly affected by potentiators, a behavior that further indicates that this protein is already totally activated with maximal forskolin and therefore behaves essentially as the normal protein.
X
ABCC7 p.Ile175Val 19491324:120:16
status: NEW
Login to comment

225 I175V may be another benign variant because its activity was comparable with or even higher than that of the native protein.
X
ABCC7 p.Ile175Val 19491324:225:0
status: NEW
Login to comment

228 Therefore, it is possible that some mutations such as I175V and I148T have a more profound effect on CFTR as a regulator of other proteins (Schreiber et al., 1999).
X
ABCC7 p.Ile175Val 19491324:228:54
status: NEW
Login to comment

PMID: 15698946 [PubMed] des Georges M et al: "High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France."
No. Sentence Comment
68 of chromosomes (frequency %) p.M1V 1 1 (0.23) p.M1K 1 1 (0.23) c.300delA 3 1 (0.23) p.P67L 3 1 (0.23) c.359insT 3 1 (0.23) p.G85E 3 3 (0.70) c.394delTT 3 1 (0.23) p.Q98R 4 1 (0.23) p.R117H 4 2 (0.47) p.Y122X 4 2 (0.47) p.Y161N 4 1 (0.23) c.621+1GNT intron 4 1 (0.23) c.621+2TNG intron 4 1 (0.23) p.I175V 5 2 (0.47) c.711+1GNT intron 5 5 (1.16) p.L206W 6 3 (0.70) p.Q220X 6 1 (0.23) p.L227R 6 1 (0.23) c.1078delT 7 2 (0.47) p.R334W 7 7 (1.63) p.R347P 7 2 (0.47) c.1215delG 7 1 (0.23) c.T5 intron 8 1 (0.23) p.D443Y 9 1 (0.23) p.I506T 10 1 (0.23) p.I507del 10 4 (0.93) p.F508del 10 259 (60.23) p.F508C 10 1 (0.23) c.1677delTA 10 1 (0.23) c.1717-8GNA intron 10 1 (0.23) c.1717-1GNA intron 10 6 (1.40) p.G542X 11 23 (5.35) p.S549R 11 1 (0.23) p.G551D 11 2 (0.47) p.R553X 11 1 (0.23) c1811+1.6kbANG intron 11 4 (0.93) c.1812-1GNA intron 11 1 (0.23) p.T582I 12 1 (0.23) p.E585X 12 2 (0,47) c.1898+1GNA intron 12 1 (0.23) [c.1898+5GNA ;p.E725K] intron 12 1 (0.23) c.1898+73TNG intron 12 1 (0.23) c.2183AANG 13 4 (0.93) c.2184insA 13 1 (0.23) p.K710X 13 4 (0.93) c.2423delG 13 1 (0.23) p.S776X 13 1 (0.23) c.2493ins8 13 1 (0.23) p.R792X 13 1 (0.23) p.K830X 13 1 (0.23) p.D836Y 14a 1 (0.23) p.W846X1 14a 1 (0.23) c.2711delT 14a 1 (0.23) c.2789+5GNA intron 14b 3 (0.70) p.S945L 15 3 (0.70) p.D993Y 16 1 (0.23) c.3129del4 17a 1 (0.23) c.3195del6 17a 1 (0.23) c.3272-26ANG intron 17a 1 (0.23) [c.3395insA ;pI148T] 17b/4 1 (0,23) p.Y1092X 17b 3 (0.70) Table 1 (continued) Mutation Location exon/intron No.
X
ABCC7 p.Ile175Val 15698946:68:298
status: NEW
Login to comment

PMID: 10923036 [PubMed] Claustres M et al: "Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France."
No. Sentence Comment
108 g D44G, 300delA, W57X, 405+1G>A, D110H, E116K, 541del4, 542del7, L137R, 621+2T>G, I175V, H199R, H199Y, C225X, V232D, Q290X, E292X, G314V, T338I, 1221delCT, W401X, Q452P, I502T, 1716+2T>C, G544S, R560S, A561E, V562I, Y569D, 1898+3A>G, 1898+5G>A, G628R(G>A), 2143delT, G673X, R851X, Q890X, S977F, 3129del4, 3154delG, 3271+1G>A, G1061R, R1066L, R1070W, 3601-17T>C, S1196X, 3732delA, G1249R, 3898insC, 4374+1G>A, del25kb.
X
ABCC7 p.Ile175Val 10923036:108:82
status: NEW
Login to comment

140 Non-F508del Mutations Found as Homozygous in a Sample of 3,710 Patients With Cystic Fibrosis Mutation n 711+1G>T 8 G542X 7 N1303K 7 2183delAA>G 5 W1282X 4 G551D 3 3905insT 3 R334W 2 R347P 2 1078delT 2 1811+1.6kbA>G 2 2113delA 2 Y1092X 2 R1162X 2 306insA 1 E92K 1 G178R 1 L227R 1 1677delTA 1 1717-1G>A 1 1717-8G>A 1 R553X 1 S549R(T>G) 1 R560S 1 V562I 1 Y569D 1 2711delT 1 S945L 1 R1158X 1 I1234V 1 3849+10kbC>T 1 Q1313X 1 del25kb 1 E831X 1 I175V 1 G314V 1 L1077P 1 produce a small quantity of functional protein as a result of a variable proportion of normal CFTR mRNA transcripts in addition to the abnormal ones (class V); 3) they are located in sites known to generate less severe mutants (external loops, residues lining the pore); and/or 4) they have been observed in CF with pancreatic sufficiency, CBAVD, and/or CF-related attenuated phenotypes only.
X
ABCC7 p.Ile175Val 10923036:140:439
status: NEW
Login to comment

PMID: 9305991 [PubMed] Seibert FS et al: "Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel."
No. Sentence Comment
106 However, only the mutations I148T, I175V, G178R, E193K, and R297Q allowed wild-type-like maturation of the protein to the fully glycosylated 170 kDa species (band C).
X
ABCC7 p.Ile175Val 9305991:106:35
status: NEW
Login to comment

120 In accordance with reduced levels of processing, the H139R, G149R, D192G, and R258G mutations significantly decreased the anion translocation capability of CFTR, whereas the properly processed I148T, I175V, and R297Q variants allowed iodide movement comparable to that of wild type.
X
ABCC7 p.Ile175Val 9305991:120:200
status: NEW
Login to comment

190 I148T, I175V, and R297Q did not adversely affect the processing, gating, or conductance of CFTR.
X
ABCC7 p.Ile175Val 9305991:190:7
status: NEW
Login to comment

199 The entire CFTR gene was not sequenced in patients with mutations I148T, I175V, or R297Q when these mutations were published.
X
ABCC7 p.Ile175Val 9305991:199:73
status: NEW
Login to comment

PMID: 9375855 [PubMed] Casals T et al: "Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: study of 19 heterozygous and 2 homozygous patients."
No. Sentence Comment
60 (Strong et al., 1991), E92K (Nunes et al., 1993), S549N (Curtis et al., 1993), I175V (Romey et al., 1994), A559T (McDowell et al., 1995), and G85E (Vázquez et al., 1996).
X
ABCC7 p.Ile175Val 9375855:60:79
status: NEW
Login to comment

PMID: 7520799 [PubMed] Romey MC et al: "Homozygosity for a novel missense mutation (I175V) in exon 5 of the CFTR gene in a family of Armenian descent."
No. Sentence Comment
10 Direct asymmetric sequencing of exon 5 using dideoxynucleotide chain termination method revealed an A to G transition at nucleotide 655 (Fig. lb), that replaces isoleucine by valine at codon 175 (1175V).
X
ABCC7 p.Ile175Val 7520799:10:161
status: NEW
Login to comment

17 Detection and identification of the substitution I175V.
X
ABCC7 p.Ile175Val 7520799:17:49
status: NEW
Login to comment

18 a. DGGE analysis of exon 5 of CFTR, showing the familial segregation of mutation I175V: the parents (lanes 2 and 3) are heterozygous (presence of heteroduplexes formed between complementary strands of the two alleles); the two affected daughters (lanes 4 and 5) arc homozygous for the mutated allele, which is situated at a lower position in the denaturing gel than the normal allele (lane 1, control DNA).
X
ABCC7 p.Ile175Val 7520799:18:81
status: NEW
Login to comment

PMID: 25735457 [PubMed] Ramalho AS et al: "Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations."
No. Sentence Comment
297 For these mutations we performed an analysis with the NNS software and found that 3 of these sites were recognized as splice sites, but only 2 (the GU created by the I175V and the GU created by I1234V) had higher scores than the normal splice site (see Table S14).
X
ABCC7 p.Ile175Val 25735457:297:166
status: NEW
Login to comment